Trial Profile
Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO RAPID VITILIGO
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2021
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Vitiligo
- Focus Therapeutic Use
- Acronyms Rapid Vitiligo
- 03 Dec 2019 Status changed from active, no longer recruiting to completed.
- 14 Jan 2019 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.
- 20 Jul 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Sep 2018.